

Formulation and Characterization of a Transdermal Patch drug delivery system loaded Turmeric extract
Abstract
Transdermal Drug Delivery Systems (TDDS) offer a means for delivering medications in a sustained and controlled manner, leading to better bioavailability and increased patient adherence. This research focuses on developing and evaluating a transdermal patch containing turmeric extract, intended for pain relief and anti-inflammatory benefits. Turmeric (Curcuma longa) is known for its bioactive components, including curcuminoids and essential oils, which exhibit significant analgesic and anti-inflammatory effects. However, its therapeutic potential is often limited by poor solubility and low bioavailability.
To address these limitations, a turmeric-based transdermal patch was prepared using the solvent casting technique. The patch utilized Hydroxypropyl Methylcellulose (HPMC) and Polyvinyl Alcohol (PVA) as film-forming polymers, glycerin as a plasticizer, and natural permeation enhancers to improve skin penetration. The prepared patches underwent evaluation for various parameters including thickness, weight variation, folding endurance, tensile strength, moisture content, drug content uniformity, and in-vitro drug release.
The findings indicated that the patches had a uniform drug distribution, desirable mechanical properties, and sustained drug release profiles. These results suggest that turmeric extract transdermal patches could serve as a promising herbal alternative for effective pain and inflammation management. In future, the further optimization and in-vivo evaluations are recommended to validate pre-clinical potential and ensure therapeutic efficacy.
References
Alhat, S., & Waghmare, D. (2023). Formulation and evaluation of transdermal patch of curcumin. International Journal of Pharmacy and Pharmaceutical Research, 27(1), 51-60.
Patil, B., Yadav, P., Yadav, A., Vishwkarma, R., Yadav, S., Yadav, P., & Takarkhede, S. (2024). Formulation and evaluation of curcumin transdermal patches for the t reatment of arthritis. International Journal of Novel Research and Development, 9(2), C274-C280.
Kanaujiya, P., Tripathi, S., & Tripathi, S. (2022). Formulation and evaluation of nanoparticle types of transdermal patches of curcumin. NeuroQuantology, 20(8), 2916-2929.
Manoj, R. V., Chethana, R., & Khousar, H. (2024). Formulation and evaluation of Curcuma longa transdermal films. International Journal of Pharmaceutical Sciences, 10(1), 48-56.
Kanaujiya, P., Tripathi, S., & Tripathi, S. (2022). A review on formulation and evaluation of curcumin-loaded transdermal patches. World Journal of Pharmacy and Pharmaceutical Sciences, 11(9), 316-329.
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010). Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica, 67(3), 217-223.
Sharma, R. A., Gescher, A. J., & Steward, W. P. (2005). Curcumin: The story so far. European Journal of Cancer, 41(13), 1955-1968.
Prausnitz, M. R., & Langer, R. (2008). Transdermal drug delivery. Nature Biotechnology, 26(11), 1261-1268.
Suryani, Halid, N. H. A., Akib, N. I., Rahmanpiu, R., & Mutmainnah, N. (2017). Preparation of curcumin nanoparticle by using reinforcement ionic gelation technique. In AIP Conference Proceedings.
Sheth, N. S., & Mistry, R. B. (2011). Formulation and evaluation of transdermal patches and to study the permeation enhancement effect of eugenol. Journal of Applied Pharmaceutical Science, 1, 96-101.
Refbacks
- There are currently no refbacks.